Mid Cap Healthcare
Stocks Ranked by
Market Capitalization
Mid Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 155 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $715B.
The largest by market cap are Dr. Reddy's Laboratories (RDY) at $9.8B, Corcept Therapeutics (CORT) at $9.78B and Halozyme (HALO) at $9.66B.
Among institutional investors, Sonida Senior Living (SNDA) drew the most net new fund positions in Q1 2026: 170 funds opened new positions, taking total fund holders up 160 (232%) quarter-over-quarter.
- Combined market cap: $715B across 155 stocks.
- Mid Cap: market cap between $2B and $10B.
- Largest constituent: Dr. Reddy's Laboratories (RDY), $9.8B market cap.
- Most net new fund positions in Q1 2026: Sonida Senior Living (SNDA), +160 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.